These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 39062770)

  • 41. Photodynamic therapy enhances the cytotoxicity of temozolomide against glioblastoma via reprogramming anaerobic glycolysis.
    Li Y; Wang D; Zhang Z; Wang Y; Zhang Z; Liang Z; Liu F; Chen L
    Photodiagnosis Photodyn Ther; 2023 Jun; 42():103342. PubMed ID: 36781008
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ABCG2 influence on the efficiency of photodynamic therapy in glioblastoma cells.
    Müller P; Abdel Gaber SA; Zimmermann W; Wittig R; Stepp H
    J Photochem Photobiol B; 2020 Sep; 210():111963. PubMed ID: 32795847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In-Vitro Use of Verteporfin for Photodynamic Therapy in Glioblastoma.
    Jeising S; Geerling G; Guthoff R; Hänggi D; Sabel M; Rapp M; Nickel AC
    Photodiagnosis Photodyn Ther; 2022 Dec; 40():103049. PubMed ID: 35932958
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interstitial 5-ALA photodynamic therapy and glioblastoma: Preclinical model development and preliminary results.
    Tetard MC; Vermandel M; Leroy HA; Leroux B; Maurage CA; Lejeune JP; Mordon S; Reyns N
    Photodiagnosis Photodyn Ther; 2016 Mar; 13():218-224. PubMed ID: 26213327
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeted and Synergic Glioblastoma Treatment: Multifunctional Nanoparticles Delivering Verteporfin as Adjuvant Therapy for Temozolomide Chemotherapy.
    Pellosi DS; Paula LB; de Melo MT; Tedesco AC
    Mol Pharm; 2019 Mar; 16(3):1009-1024. PubMed ID: 30698450
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NQO1 Is Regulated by PTEN in Glioblastoma, Mediating Cell Proliferation and Oxidative Stress.
    Luo S; Lei K; Xiang D; Ye K
    Oxid Med Cell Longev; 2018; 2018():9146528. PubMed ID: 30595797
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
    Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
    Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
    Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
    J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel Targeting of Transcription and Metabolism in Glioblastoma.
    Su YT; Chen R; Wang H; Song H; Zhang Q; Chen LY; Lappin H; Vasconcelos G; Lita A; Maric D; Li A; Celiku O; Zhang W; Meetze K; Estok T; Larion M; Abu-Asab M; Zhuang Z; Yang C; Gilbert MR; Wu J
    Clin Cancer Res; 2018 Mar; 24(5):1124-1137. PubMed ID: 29254993
    [No Abstract]   [Full Text] [Related]  

  • 50. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
    Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
    Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
    [TBL] [Abstract][Full Text] [Related]  

  • 51. γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth.
    Bui TT; Nitta RT; Kahn SA; Razavi SM; Agarwal M; Aujla P; Gholamin S; Recht L; Li G
    BMC Cancer; 2015 Apr; 15():225. PubMed ID: 25884624
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low Dose of Doxorubicin Potentiates the Effect of Temozolomide in Glioblastoma Cells.
    Villodre ES; Kipper FC; Silva AO; Lenz G; Lopez PLDC
    Mol Neurobiol; 2018 May; 55(5):4185-4194. PubMed ID: 28612256
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
    Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
    Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
    Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Juglone in Combination with Temozolomide Shows a Promising Epigenetic Therapeutic Effect on the Glioblastoma Cell Line.
    Barciszewska AM; Belter A; Gawrońska I; Giel-Pietraszuk M; Naskręt-Barciszewska MZ
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cedrol suppresses glioblastoma progression by triggering DNA damage and blocking nuclear translocation of the androgen receptor.
    Chang KF; Huang XF; Chang JT; Huang YC; Weng JC; Tsai NM
    Cancer Lett; 2020 Dec; 495():180-190. PubMed ID: 32987140
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synergistic Effects of Temozolomide and Doxorubicin in the Treatment of Glioblastoma Multiforme: Enhancing Efficacy through Combination Therapy.
    Dhungel L; Rowsey ME; Harris C; Raucher D
    Molecules; 2024 Feb; 29(4):. PubMed ID: 38398592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Photodynamic therapy of Glioblastoma cells using doped conjugated polymer nanoparticles: An in vitro comparative study based on redox status.
    Caverzán MD; Beaugé L; Chesta CA; Palacios RE; Ibarra LE
    J Photochem Photobiol B; 2020 Nov; 212():112045. PubMed ID: 33022469
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A co-culture model with brain tumor-specific bioluminescence demonstrates astrocyte-induced drug resistance in glioblastoma.
    Yang N; Yan T; Zhu H; Liang X; Leiss L; Sakariassen PØ; Skaftnesmo KO; Huang B; Costea DE; Enger PØ; Li X; Wang J
    J Transl Med; 2014 Oct; 12():278. PubMed ID: 25280402
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nanobody-Targeted Photodynamic Therapy Selectively Kills Viral GPCR-Expressing Glioblastoma Cells.
    De Groof TWM; Mashayekhi V; Fan TS; Bergkamp ND; Sastre Toraño J; van Senten JR; Heukers R; Smit MJ; Oliveira S
    Mol Pharm; 2019 Jul; 16(7):3145-3156. PubMed ID: 31244224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.